Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Troubleshooting of bioinequivalence of compound valsartan tablets].

Shao D, Zhang YF, Zhan Y, Chen XY, Zhong DF.

Yao Xue Xue Bao. 2014 Apr;49(4):524-9. Chinese.

PMID:
24974472
2.

Pharmacokinetic properties and bioequivalence of two irbesartan/ hydrochlorothiazide fixed-dose combination tablets in healthy male Chinese volunteers.

Liu J, Wu L, Hu X, Wu G, Zheng Y, Zhou H, Zhai Y, Zhu M, ShenTu J.

Int J Clin Pharmacol Ther. 2015 Jul;53(7):573-81. doi: 10.5414/CP202208.

PMID:
25828636
3.

Quantitative analysis of valsartan by two-dimensional liquid chromatography (2D-HPLC) and its application in a bioequivalence study in Chinese volunteers
.

Zhang M, Deng Y, Cai HL, Fang PF, Yan M, Zhang BK, Wu YQ.

Int J Clin Pharmacol Ther. 2017 Apr;55(4):373-381. doi: 10.5414/CP202762.

PMID:
28025969
4.

Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.

Spínola AC, Almeida S, Filipe A, Neves R, Trabelsi F, Farré A.

Clin Ther. 2009 Sep;31(9):1992-2001. doi: 10.1016/j.clinthera.2009.09.002.

PMID:
19843489
5.
6.

Pharmacokinetic comparison of amlodipine adipate/valsartan fixed-dose combination with amlodipine besylate/valsartan fixed-dose combination in healthy volunteers.

Nam JH, Oh M, Kim HJ, Han SK, Kim EJ, Song GS, Kim EY, Shin JG, Ghim JL, Kim HS.

Int J Clin Pharmacol Ther. 2015 Jan;53(1):66-74. doi: 10.5414/CP202045.

PMID:
25034618
7.

Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.

Iqbal M, Khuroo A, Batolar LS, Tandon M, Monif T, Sharma PL.

Clin Ther. 2010 Mar;32(3):588-96. doi: 10.1016/j.clinthera.2010.03.004.

PMID:
20399995
8.

Combination of losartan and hydrochlorothiazide: in vivo bioequivalence.

Koytchev R, Ozalp Y, Erenmemisoglu A, van der Meer MJ, Alpan RS.

Arzneimittelforschung. 2004 Sep;54(9A):611-7.

PMID:
15497669
9.

Comparative bioavailability of two irbesartan/hydrochlorothiazide tablet formulations in Indonesian healthy subjects.

Sasongko L, Harahap Y, Prasaja B, Lusthom W, Setiawan EC, Meliala RS, Lipin.

Arzneimittelforschung. 2010;60(12):749-53. doi: 10.1055/s-0031-1296350.

PMID:
21265466
10.

Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.

Kim JE, Ki MH, Yoon IS, Cho HJ, Kim RS, Tae Kim G, Kim DD.

Clin Ther. 2014 Feb 1;36(2):273-9. doi: 10.1016/j.clinthera.2014.01.004.

PMID:
24529292
11.

Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions.

Tjandrawinata RR, Setiawati E, Yunaidi DA, Simanjuntak R, Santoso ID, Susanto LW.

Drug Des Devel Ther. 2013 Aug 20;7:841-7. doi: 10.2147/DDDT.S47272. eCollection 2013.

12.

Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (polycap): a five-arm phase I crossover trial in healthy volunteers.

Patel A, Shah T, Shah G, Jha V, Ghosh C, Desai J, Khamar B, Chakraborty BS.

Am J Cardiovasc Drugs. 2010;10(2):95-103. doi: 10.2165/11532170-000000000-00000.

PMID:
20334446
13.

Effect of the combination of lisinopril and hydrochlorothiazide on the bioequivalence of tablet formulations.

Koytchev R, Ozalp Y, Erenmemisoglu A, van der Meer MJ, Alpan RS.

Arzneimittelforschung. 2004 Sep;54(9A):605-10.

PMID:
15497668
14.

Pharmacokinetic and bioequivalence study of two brands of valsartan tablets in healthy male volunteers.

Zakeri-Milani P, Valizadeh H, Islambulchilar Z, Nemati M.

Arzneimittelforschung. 2010;60(2):76-80. doi: 10.1055/s-0031-1296252.

PMID:
20329655
15.

Pharmacokinetic comparison and bioequivalence evaluation of losartan/ hydrochlorothiazide tablet between Asian Indian and Japanese volunteers.

Kumar S, Monif T, Khuroo A, Reyar S, Jain R, Singla AK, Kurachi K.

Int J Clin Pharmacol Ther. 2014 Jan;52(1):39-54. doi: 10.5414/CP201927.

PMID:
24290414
16.

Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers.

Gascón AR, Cuadrado A, Solinís MA, Hernández RM, Ramírez E, Dalmau R, Pedraz JL.

Int J Clin Pharmacol Ther. 2003 Jul;41(7):309-15.

PMID:
12875347
17.

Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers.

Jeon JY, Im YJ, Kim Y, Han SM, Jo MJ, Shin DH, Yoo JS, Moon BK, Kim BK, Lee BH, Choi YH, Cho BS, Jang HY, Chae SW, Kim MG.

Drug Dev Ind Pharm. 2013 Sep;39(9):1296-9. doi: 10.3109/03639045.2012.725732. Epub 2012 Oct 3.

PMID:
23030309
18.
19.

Bioequivalence study of two different film-coated tablet formulations of losartan-hydrochlorothiazide in healthy volunteers.

Neves R, Almeida S, Filipe A, Spínola AC, Abolfathi Z, Yritia M, Ortuño J.

Arzneimittelforschung. 2008;58(8):369-75. doi: 10.1055/s-0031-1296523.

PMID:
18807576
20.

Supplemental Content

Support Center